Foto: Kristian L. Forsberg
Nadezhda Latysheva
Overingeniør
Arbeidsområder
Espen Waage Skjeflo,
Line Holtet Evensen,
Søren Beck Jensen,
Nadezhda Latysheva,
Annika Elisabet Michelsen,
Thor Ueland
m.fl.:
Complement factors B, D, C3bBbP and risk of future venous thromboembolism
Clinical Immunology 2023 DOI
Søren Beck Jensen,
Nadezhda Latysheva,
Kristian Hindberg,
Thor Ueland
:
Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies
Omri Snir,
line Wilsgård,
Nadezhda Latysheva,
Casper Ullsten-Wahlund,
Sigrid Kufaas Brækkan,
Kristian Dalsbø Hindberg
m.fl.:
Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism
Carolina E. Touw,
Banne Nemeth,
Willem M. Lijfering,
Raymond A. van Adrichem,
line Wilsgård,
Nadezhda Latysheva
m.fl.:
Effect of lower-leg trauma and knee arthroscopy on procoagulant phospholipid-dependent activity
Bjarne Østerud,
Nadezhda Latysheva,
Christian Schoergenhofer,
Bernd Jilma,
John-Bjarne Hansen,
Omri Snir
:
A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation
Ellen-Sofie Hansen,
Fridtjof Balteskard Rinde,
Magnus Edvardsen,
Kristian Hindberg,
Nadezhda Latysheva,
Pål Aukrust
m.fl.:
Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism
Cathrine Ramberg,
Simin Jamaly,
Nadezhda Latysheva,
line Wilsgård,
Timofey Sovershaev,
Omri Snir
m.fl.:
A modified clot-based assay to measure negatively charged procoagulant phospholipids
Cathrine Ramberg,
Line Wilsgård,
Nadezhda Latysheva,
Sigrid Kufaas Brækkan,
Kristian Hindberg,
Timofey Sovershaev
m.fl.:
Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
Ellen-Sofie Hansen,
Kristian Hindberg,
Nadezhda Latysheva,
Pål Aukrust,
Thor Ueland,
John-Bjarne Hansen
m.fl.:
Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism
Ina Isabella Høiland,
Robin Amanda Liang,
Sigrid Kufaas Brækkan,
Kristin Pettersen,
Judith K Ludviksen,
Nadezhda Latysheva
m.fl.:
Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism
Terry Solomon,
John D. Lapek,
Søren Beck Jensen,
William W. Greenwald,
Kristian Hindberg,
Hiroko Matsui
m.fl.:
Identification of common and rare genetic variation associated with plasma protein levels using whole-exome sequencing and mass spectrometry
Circulation: Genomic and precision medicine 2018 DOI
Simin Jamaly,
Cathrine Ramberg,
Randi Olsen,
Nadezhda Latysheva,
Paul Webster,
Timofey Sovershaev
m.fl.:
Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis
Søren Beck Jensen,
Kristian Hindberg,
Terry Solomon,
Erin N. Smith,
John D. Jr. Lapek,
David J. Gonzalez
m.fl.:
Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics
Journal of Thrombosis and Haemostasis 2018 DOI
Ina Isabella Høiland,
Robin Amanda Liang,
Kristian Hindberg,
Nadezhda Latysheva,
Ole-Lars Brekke,
Tom Eirik Mollnes
m.fl.:
Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism
Irina Starikova,
Simin Jamaly,
Antonio Sorrentino,
T Blondal,
Nadezhda Latysheva,
Mikhail Sovershaev
m.fl.:
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals
Thrombosis Research 2015 DOI
Synnøve Magnussen,
Elin Synnøve Hadler-Olsen,
Nadezhda Latysheva,
Emma Pirila,
Sonja Eriksson Steigen,
Robert Hanes
m.fl.:
Tumour Microenvironments Induce Expression of Urokinase Plasminogen Activator Receptor (uPAR) and Concomitant Activation of Gelatinolytic Enzymes
Bjarne Østerud,
Nadezhda Latysheva,
John Bjarne Hansen,
Omri Snir
:
“A rapid, sensitive, and specific assay to measure tissue factor activity based on chromogenic determination of thrombin generation”: reply
Journal of Thrombosis and Haemostasis 2023 DOI
Nadezhda Latysheva
:
When should we stop inflammation?
2017 FULLTEKST
Nadezhda Latysheva,
Dana Meknas
:
Bør pasienter med hjernesvulst få forebyggende blodproppbehandling?
2017 FULLTEKST
Helle Jørgensen,
Sigrid Kufaas Brækkan,
Olga Dziewiecka,
Lars Daae Horvei,
Gro Grimnes,
Ina Isabella Høiland
m.fl.:
Forskningstorget Tromsø 24-25. september
2015
Nadezhda Latysheva
:
Proteins may help to diagnose venous thrombosis
2015 FULLTEKST
Irina Starikova,
Simin Jamaly,
Antonio Sorrentino,
Thorarinn Blondal,
Nadezhda Latysheva,
Cathrine Ramberg
m.fl.:
DIFFERENTIAL EXPRESSION OF MIRNAS IN PLASMA AND PERIPHERAL BLOOD MONONUCLEAR CELLS COLLECTED FROM PATIENTS WITH
UNPROVOKED VENOUS THTOMBOEMBOLISM AND HEALTHY CONTROL
INDIVIDUALS
2015
Cathrine Ramberg,
Simin Jamaly,
Nadezhda Latysheva,
Erin Mathiesen Hald,
Vladimir Tichelaar,
John Bjarne Hansen
:
IMPACT OF A FAT-TOLERANCE TEST ON PLASMA CONCENTRATION AND
SIZE DISTRIBUTION OF EXTRACELLULAR VESICLES ASSESSED BY
NANOPARTICLE TRACKING ANALYSIS
2015
Simin Jamaly,
Vladimir Tichelaar,
Randi Olsen,
Erin Mathiesen Hald,
Cathrine Ramberg,
Nadezhda Latysheva
m.fl.:
IMPACT OF VARIOUS ANTICOAGULANTS AND STORAGE TIME ON PLASMA CONCENTRATION AND SIZE DISTRIBUTION OF EXTRACELLULAR
VESICLES
2015
Gunbjørg Svineng,
Synnøve Magnussen,
Elin Synnøve Hadler-Olsen,
Nadezhda Latysheva,
Emma Pirila,
Sonja Eriksson Steigen
m.fl.:
Stromal induced expression of uPAR
2013
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →
